The influence of nitric oxide on perigeniculate GABAergic cell activity in the anaesthetized cat by Rivadulla, Casto et al.
European Journal of Neuroscience, Vol. 8, pp. 2459-2466, 1996 
The Influence of Nitric Oxide on Perigeniculate GABAergic Cell 
Activity in the Anaesthetized Cat 
C. Rivadulla, R. Rodríguez, S. Martínez-Conde, C. Acuña and J. Cudeiro 
Abstract 
We have tested the effect of iontophoretic application of the nitric oxide synthase inhibitor l-nitroarginine on the 
activity of a population of 53 perigeniculate (PGN) cells, recorded extracellularly in the anaesthetized paralysed cat. 
In all cells tested with visual stimulation during l-nitroarginine application (n= 15), the visually elicited responses 
were markedly reduced, on average by 63 ± 15%, and there was a reduction in spontaneous activity too. This effect 
was blocked by co-application of the substrate for nitric oxide synthase, l-arginine, but not by the inactive d-isoform, 
although application of l-arginine alone was without effect. Pressure application of the nitric oxide donor S-nitroso-N-
acetylpenicillamine (SNAP) elevated both visual responses and spontaneous discharge, an effect also seen with a 
second nitric oxide donor, sodium nitroprusside (n= 12). The nitric oxide synthase inhibitor l-nitroarginine was 
applied to a sub-population of seven cells and it selectively decreased NMDA mediated excitation (reduction 80 % 
14%) with little or no effect on the excitation mediated by α-amino-3-hydroxy-5-5-methyl-4-isoxazole-propionic acid 
(AMPA) or quisqualate (effects not statistically significant), and it had no effect (n= 7) on excitation mediated by the 
metabotropic agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD). Furthermore, application of 
SNAP also increased the magnitude of excitatory responses mediated by NMDA receptors. On a different population 
of seven cells, application of the new NO donor diethylamine-nitric oxide (DEA-NO) enhanced the actions Of 
NMDA without an effect on responses to AMPA. These effects are qualitatively and quantitatively similar to those 
we have previously described for X and Y type cells in the dorsal lateral geniculate nucleus (dLGN), despite the 
known opposite effects of acetylcholine (ACh) application in the dLGN and PGN (ACh is co-localized with nitric 
oxide synthase at both sites). We propose that within the PGN nitric oxide acts to enhance transmission utilizing 
NMDA receptors selectively (thereby interacting with the globally inhibiting effect of ACh at this site) to enhance 
visual responses, reducing or removing the non-specific inhibitory drive from PGN to dLGN seen in the spindling 
activity of slow-wave sleep. These effects will act in concert with the facilitatory actions of both ACh and nitric oxide 
within the dLGN proper, and will thereby enhance the faithful transmission of visual information from retina to 
cortex. 
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Introduction  
The perigeniculate nucleus (PGN), the visual component of the thalamic reticular nucleus, is a major 
extrinsic source of GABAergic innervation to the dorsal lateral geniculate nucleus (dLGN). The cells in 
the PGN have been shown to be immunoreactive for GABA, and they send their axons back into the 
thalamus, innervating both relay cells and local GABAergic interneurons (Fitzpatrick et al., 1984; 
Montero and Singer, 1984; Rinvik et al.,1987). The PGN receives visual input both from collaterals of 
dLGN relay cells (Ahlsen et al., 1978; Ferster and LeVay, 1978; Friedlander et al., 1981; Ahlsen and 
Lindstrom, 1982) and from collaterals of the dense descending corticofugal projection to the dLGN 
(Updyke, 1975, 1977; Boyapati and Henry,1984; Robson, 1984). This pattern of connectivity allows PGN 
cells to mediate the recurrent inhibition previously shown to operate on dLGN relay cells (Singer and 
Bedworth, 1973; Dubin and Cleland, 1977; Lindstrom, 1982). In addition, PGN cells receive a number of 
non-visual modulatory inputs, including cholinergic fibres from the parabrachial region of the brainstem, 
which also innervate the dLGN (Kimura et al., 1981; Ahlsen and Lo, 1982; DeLima and Singer, 1987; 
Steriade et al., 1987; Bickford et al., 1993; Funke and Eysel,1993).  
Pharmacological investigations have demonstrated that acetyl- choline (ACh) markedly increases the 
discharge rate of dLGN relay cells, while PGN cells, like the intrinsic inhibitory interneurons within the 
dLGN, are inhibited (Ben Ari et al., 1976; Godfraind. 1978 Sillito et al., 1983; Eysel et al., 1986; 
McCormick and Prince, 1987; Francesconi et al., 1988). More recently, it has been shown that these 
cholinergic axons arising in the parabrachial region of the brainstem reach both dLGN and PGN and stain 
positively for nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase, a marker for the 
enzyme nitric oxide synthase (NOS) (Bickford et al., 1993). We have provided evidence that nitric oxide 
(NO) enhances the activity of dLGN relay cells activity by permitting full expression of NMDA evoked 
actions. This enhancement is apparently unrelated to the direct action of ACh in this nucleus (Cudeiro et 
al., 1994a, b; 1996). This raises the interesting possibility that activity in cholinergic fibres from the 
parabrachium may also act on PGN cells not only by the action of ACh itself but also via release of NO 
(co-loca1ized with ACh; see Bickford et al., 1993), and in tum be involved in the GABA mediated 
control exerted by PGN, both within the PGN itse1f and on latera1 geniculate cells. Here we have 
addressed this issue and concentrated mainly on two major questions; (i) Does NO influence the activity 
of cells in the PGN? (ii) If this is the case, does this action (like that we have previously shown in the 
dLGN) involve an action on NMDA mediated activity? A brief account of the findings has been 
published in abstract form (Rivadulla et al., 1995)  
Materials and methods 
Animal preparation, recording and iontophoretic application of drugs  
Experiments were carried out on adult cats anesthetized with a mixture of N2O (70%), O2 (30%) and 
halothane (0.1-5%) and para1ysed with gallarnine triethiodide (10 mg/kg/h). Experimenta1 procedures for 
preparation and maintenance of cats and visua1 stimulation have been described previously (Cudeiro et 
al., 1996). Seven-barrelled micropipettes were used for recording single-unit activity and iontophoretic 
application of drugs in the PGN. Drug barrels contained a selection of the following solutions: NaCl (3 M 
for extracel1ular recording), L-arginine (L-Arg, 10 mM, pH 6.0), D-arginine (D-Arg, 10 mM, pH 6.0), 
NG-nitro-L-arginine (L-NOArg, 10 mM, pH 6.0), sodium nitroprusside (SNP, applied by pressure 
ejection, 10 mM), S-nitroso-N-acetylpenicillamine (SNAP, applied by pressure ejection, 10 mM), 
diethylamine-nitric oxide complex sodium (DEA-NO, 10 mM, pH 8), NMDA (0.1 M, pH 8), D-2-amino-
5- phosphonova1erate (APV, 25 mM, pH 8), α-amino-3-hydroxy-5-5- methyl-4-isoxazole-propionic acid 
(AMPA, 15 mM, pH 8), quisqualate (QUIS, 25 mM, pH 8.0), (1S,3R)-1-aminocyclopentane-1,3-dicarb- 
oxylic acid (ACPD, 50 mM, pH 8.0), ACh (0.2 M, pH 4.5) or pontamine sky blue (2% w/v, in 0.5 M 
sodium acetate solution for histological reconstruction).  
Pipettes tips were broken back to diameters ranging from 3 to 10 µm, and each drug barrel was subject 
to a constant retention current of 5-25 nA of appropriate polarity. Perigeniculate cells were identified by 
several criteria including anatomical localization, responses to visual stimulation, binocularity (Dubin and 
Cleland, 1977; Wrobel and Tarnecki, 1984; Xue et al., 1988; Uhlrich et al., 1991) and on the basis of their 
responses to iontophoretically applied ACh, which produced a powerful suppression of cell discharge (see 
Fig. 1). The normally high spontaneous activity is immediately and markedly suppressed by application 
of ACh, the opposite effect to that seen in LGN relay cells. In addition, histological verification of the 
anatomical1ocation of a number of the recording sites was carried out by passing negative current (20-40 
µA) through an electrode barrel containing pontarnine sky blue for 15-20 min. After neutral red staining, 
the location of the blue spots marking the recording sites was determined 
Visual stimulation and experimental design  
Single unit data were collected and visual stimuli were produced under computer control (Visual 
Stimulation System, Cambridge Electronic Design, Cambridge, UK; for details see Sillito et al., 1993). 
Stimuli routinely consisted of sinusoidal drifting gratings with spatial and temporal frequencies 
qualitatively selected to produce the best response. The mean luminance (L) was 14 cd/m2 and stimulus 
contrast [(Lmax - Lmin)/(Lmax + Lmin)] was held at 0.36-0.7. For quantitative assessment of receptive field 
parameters a peristimulus histogram (PSTH) technique was used. Our basic experimental paradigm 
involved establishing control responses to a visual stimulus, which was then repeated during continuous 
iontophoretic application of an inhibitor of nitric oxide synthesis, either alone or in combination with D-
Arg or L-Arg. Typically, responses were averaged over 10 stimulus presentations (each presentation 
involved 10 cycles of the sinusoidal grating) and were assessed from the accumulated counts in the 
binned and pooled data in the PSTHs. Where error bars are show these are +1 SEM. To examine the 
nature of the action of NOS inhibitors on excitatory responses evoked by exogenously applied NMDA we 
used pulsatile iontophoretic application of NMDA before and during continuous application of L-NOArg 
(again a1one or in combination with D-Arg or L-Arg). The same protocol was used for the non-NMDA 
agonists AMPA, QUIS and ACPD. Pressure application of the NO donors SNP or SNAP a1one or in 
combination with NMDA and iontophoretical ejection of DEA-NO were a1so quantitatively examined in 
the same manner. The magnitude of the drug iontophoretic application current was selected on the basis 
of initial qualitative observations. In several experiments we included one barrel containing 0.9% NaCl, 
as a control to eliminate pressure mediated effects; volumes ejected ranged from 5 to 7 nl. It was clear 
that the increment in firing rate as a result of pressure ejection of both SNP and SNAP was not 
artefactua1ly induced by the ejection technique, since similar pressure ejection of the saline (vehicle) had 
no effect on the spontaneous activity of the cells.  
 
 
 
FIG. 1. Responses of single PGN cells, typical of those in this study. The top two PSTHs show the spontaneous activity of the cell 
(left) and the effect of iontophoretic application of ACh (right), which causes a rapid inhibition of spiking activity which continues 
for the duration of the application. The responses of the same cell to iontophoretic application of the excitatory amino acids NMDA, 
AMPA and QUIS are shown below. The effects of these compounds, unlike that of ACh, are similar in nature to those obtained 
during application to dLGN cells (where ACh is clearly excitatory). Finally, the excitatory response of a different cell obtained to 
application of the metabotropic agonist ACPD is shown in the bottom right PSTH. Arrowed horizontal1ines under the PSTHs 
indicate ejection times. Note that there are three different time scales in this figure.  
Results  
The data reported here derive from a total population of 53 cells recorded in PGN. All cells had 
receptive fields centred less than 13° (degrees of visual angle) from the area centrales, and recording sites 
were located no more than 1000 µm above the upper border of lamina A of the dLGN.  
Effect of application of NOS inhibitors on PGN cells activity  
All cells tested showed marked response reductions to visual stimulation during iontophoretic 
application of the NOS inhibitor L-NOArg (n = 15). This effect was blocked by concurrent ejection of L-
Arg and unaltered by D-Arg , the biologically inactive isomer. This is shown in the PSTHs of Figure 2, 
which illustrates the response of a PGN cell to a drifting sinusoidal grating. In the upper row, the control 
response to visual stimulation alone is compared with those obtained during continuous iontophoretic 
ejection of L-NOArg, showing the temporal progression of the inhibitory effect. The visual response was 
clearly reduced by some 66% after 5 min of application. In the middle row, this cell was tested again after 
a recovery period, and the effect of simultaneous ejection of both L-NOArg and L-Arg during visual 
stimulation is illustrated. In this case neither the visual response nor spontaneous activity (horizontal 
dotted lines) was altered. Finally, after another recovery period, L-NOArg was applied together with D-
Arg. Here again L-NOArg produced a marked reduction of the visual response, reinforcing the view that 
the suppressive effects of this compound are specific, and are the result of competitive inhibition of NOS. 
For this cell, application of L-Arg alone was without significant effect, the visual response being equal to 
the control level. On average, visual responses were reduced by 63 ± 15% SEM (P < 0.0001, Wilcoxon 
test). There was a similar degree of suppression of background activity in all cases.  
 
 
 
FIG. 2. The effects of L-NOArg, L-Arg and D-Arg on responses of a PGN cell to visual stimulation. The top row of PSTHs 
documents the effect of application of L-NOArg during presentation of a visual stimulus (a full-field sinusoidal drifting grating; 
spatial frequency = 0.4 cycle/degree; temporal frequency = 1 cycle/s). The control pre-drug response is on the left, and the middle 
PSTH shows activity during repeated presentation of the visual stimulus, 3 min after beginning the application of L-NOArg. The 
right PSTH shows a slightly increased inhibitory effect as the L-NOArg application is continued to 5 min. The second row of 
PSTHs again shows a control response, taken after recovery from the effect of L-NOArg application, and the middle and right 
PSTHs show no effect from application of L-NOArg, when it is applied in conjunction with L-Arg. The third row of PSTHs shows, 
from left to right, control and responses after 3 and 5 min of combined application of L-NOArg and D-Arg. Here again the 
inhibitory effects of L-NOArg are revealed. The lowest row of PSTHs documents the lack of effect of application of L-Arg alone; 
even after 5 min of application the visual responses are entirely unaffected. The dotted horizontal lines represent 
spontaneous/background activity. The bin width was 20 ms and the PSTH duration 1 s; each PSTH shows the average of 10 trials.  
Effect of application of NO donors  
The effects of pressure ejection of the chemically unrelated NO donors SNAP and SNP on 
spontaneous activity are shown in Figure 3A. Application of either donor produced a clear increase in 
discharge rate. This type of effect (P < 0.01, Wilcoxon test) was found in all cell tested (n = 12) and the 
spontaneous activity was enhanced by ~130%. As can be seen in the PSTHs, the effect of the app1ication 
outlasted the period of ejection by many seconds. Furthermore, the NO donors (SNAP, in this case) were 
partially able to restore normal activity when they were app1ied concomitantly with L-NOArg (Fig. 3B). 
We also tested the application of SNAP on those cells studied with visual stimulation (n = 8). A typical 
example is illustrated in Figure 4A. The control response is on the left and the PGN cel1 was stimulated 
with a sinusoidal drifting grating. On the right, the effect of SNAP application is shown. There is a 
significant enhancement of the visual response (from 40 ± 2 to 52 ± 3 spikes/s; p < 0.05 Wilcoxon test, 10 
presentations)  
 
 
 
FIG. 3. (A) The effect of application of the NO donors SNAP and SNP on the spontaneous activity of PGN cells. In the upper 
PSTH a 6 s pressure ejection of SNAP caused an increase in firing in this cell after ~4 s, which peaked ~6--10 s later (well after the 
end of drug ejection) and declined over the next 30-40 s. These values are typical of the population of 12 cells tested this way. The 
lower PSTH in (A) shows the effect of application of the NO donor SNP on the spontaneous activity of another PGN cell; a 4 s 
pressure ejection of SNP caused a rise in firing, more rapid in onset than that of SNAP. Each PSTH shows the average of five trials 
and the bin width was 1 s. (B) Curve showing the temporal progression of the effect of NOS blockade on spontaneous activity of 
another PGN cell (mean ± SEM). After 4 min of L-NOArg ejection, the spontaneous discharge declined by ~61 %. Application of 
the NO donor SNAP significantly increased the spontaneous discharge, almost restoring the background activity to control levels.  
  
 
 
 
FIG. 4. (A) The effect of SNAP on the response of a PGN cell to visua1 stimulation. The left PSTH shows a control response to a 
drifting sinusoidal grating (spatia1 frequency = 0.1 cycle/degree; temporal frequency = 3.3 cycles/s; average of 10 presentations; bin 
width = 10 ms). On the right the same visua1 stimulus was employed, but it was presented during continuous pressure (2 bar) 
application of SNAP. (B) Summary bar chart showing the effect of pressure application of the NO donor SNAP on excitatory 
responses of seven PGN cells to exogenously applied NMDA. (C) Bar chart comparing the mean excitatory responses of a 
population of seven PGN cells to NMDA, AMPA and QUIS alone (open bars) and in the presence of L-NOArg (80 nA, shaded bars, 
responses measured 4 min after L-NOArg onset). In B and C values are the population mean in spikes/s ± 1 SEM, measured over a 
variable period of time starting and finishing when a significant change in the discharge of the cells was detected, according to the 
test of Sea1 et al. (1983) which determines the point of change using the maximum likelihood approach.  
Effect of application of NOS inhibitors and donors on NMDA, AMPA, QUIS and ACPD evoked responses  
In Figure 4B we illustrate the effect of application of the nitric oxide donor SNAP on NMDA evoked 
responses. Like its effect of visually driven responses (see Figure 4A), SNAP ejection significantly 
increased responsiveness to NMDA application (28.6 ± 6%, n = 6, p < 0.05, Wilcoxon test). The effect of 
ejection of L-NOArg on NMDA, AMPA and QUIS evoked responses was tested on seven cells. 
Examples of these responses are shown in Figure 1; application of the NOS inhibitor resulted in a clear 
suppression of NMDA evoked excitation, while responses to AMPA and QUIS were largely unaffected.~ 
This is illustrated in Figure 4C where both effects are compared. Ejection of L-NOArg effectively 
reduced the responses to NMDA (left side) by 80.14% (P < 0.0001, Wilcoxon test). Responses to AMPA 
and QUIS were much less reduced (~12.5%, not significant). To investigate the effect of NOS inhibitors 
further, L-NOArg was ejected concomitantly with the specific metabotropic agonist ACPD. As shown in 
Figure 5, the excitatory respose evoked by ACPD application (Fig. 5A, left PSTH) was essentially 
unaffected by L- NOArg (right PSTH). Figure 5B shows the mean response obtained for a population of 
seven cells.  
 
 
 
FIG. 5. (A) The PSTH on the left shows the excitatory response elicited by iontophoretically applied ACPD (80 nA, 4 s; see arrows) 
on a PGN cell. On the right, the effect of simultaneous ejection of ACPD and the NOS inhibitor L-NOArg (80 nA, continuous 
application) is illustrated. It is clear that the presence of the NOS inhibitor does not significantly affect the ACPD action. (B) Mean 
responses obtained for a population of seven cells. The bin width was 1 s.  
In a different group of seven cells, application of the new NO donor DEA-NO enhanced basal 
discharge, but not in the presence of the NMDA receptor antagonist APV (Fig. 6A). Furthermore, 
application of DEA-NO enhanced the excitatory responses to NMDA (Fig. 6A), but, significantly, did not 
alter the response to AMPA (Fig. 6B) (tested in the presence of continuous iontophoretic ejection of APV 
to avoid the effects of NMDA receptor mediated spontaneous activity shown in Fig. 6A).   
 
 
 
FIG. 6. (A) A bar chart showing the effect on basa1 discharge of the NO donor DEA.NO alone (column 2), APV alone (column 3) 
and the two together (column 4). Application of NMDA alone and in combination with DEA-NO is shown in the two columns on 
the right. (B) Comparison of the excitatory responses elicited by AMPA and AMPA + DEA-NO in the presence of continuous 
application of APV. The APV was applied with currents sufficient to suppress responses to NMDA selectively (data not shown). 
Each bar shows the mean for a population of seven cells (+SEM).  
Discussion  
These data show that the activity of PGN cells, like that of dLGN cells, can be markedly affected by 
iontophoretic application of the NOS inhibitor L-NOArg. That such an effect seems to be specifically due 
to inhibition of NO synthesis is supported by the following observations. (i) The inhibitory effect of L-
NOArg was antagonized by co-application of L-Arg, the biological substrate for the enzyme NOS. (ii) In 
a similar paradigm D-Arg, the biologically inactive isomer of arginine, was unable to restore normal 
activity. (iii) Application of the chemically unrelated NO donors SNP, SNAP or DEA-NO significantly 
increased both spontaneous activity and visually driven responses. It is known that the sole source of 
NOS in the dLGN/PGN complex is the cholinergic pathway from the parabrachium (Bickford et al., 
1993) where NADPH-diaphorase, a marker for NOS has been shown to co-localize with ACh. However, 
the effects of ACh at the two sites are opposite, with enhancement of dLGN activity and suppression of 
PGN activity (Ben Ari et al., 1976; Godfraind, 1978; Sillito et al., 1983; Eysel et al., 1986; McCormick 
and Prince, 1987; Francesconi et al., 1988). Surprisingly, then, the data presented here show that blockade 
of NO synthesis in the PGN produces a potent and relatively selective reduction of NMDA evoked 
excitation, just as we have previously demonstrated for cells in the dLGN (Cudeiro et al., 1994b, 1996). A 
direct action of L-NOArg on NMDA receptors is unlikely, as L-NOArg has previously been shown 
neither to produce any effect on NMDA membrane currents nor affect [3H]MK-801 binding (Dawson et 
al., 1991). An interesting point arising from our results is the finding that L-Arg itself, while antagonizing 
the block of NO production, itself produces no further increase in firing. Again this mirrors our 
observations in the dLGN (Cudeiro et al. 1994a, b). In a previous study we excluded the possibility that 
this action of NOS blockade was NMDA selective only by virtue of the voltage selective nature of 
NMDA responses, by demonstrating that the effect of NOS blockade was still present when cells were 
hyperpolarized by exogenous application of GABA (Cudeiro et al., 1996). Although we have not repeated 
this experiment here, it seems unlikely that there should exist two separate mechanisms for the 
enhancement of NMDA responses at the level of the LGNI PGN complex. Furthermore, the inability of 
DEA-NO to enhance AMPA responses in the presence of APV suggests an NMDA specific action.  
We propose that in normal function (or at least in the experimental conditions outlined here) available 
NOS, the enzyme producing NO, is fully active, being a rate limiting step in the control of NMDA 
mediated excitation. The similarity between these results and those obtained in the dLGN proper is at first 
surprising, given the opposite polarity of the effect of ACh application. Although this suggests a common 
mechanism of NO action operating throughout the dLGNI PGN complex in the cat, the difference in the 
actions of ACh (and by extension the actions of the parabrachial input) at these two sites must also be 
accounted for in any explanation for these effects. While the synaptic pharmacology of the PGN is as yet 
not fully characterized, it is clear that these cells respond in an excitatory fashion to the application of the 
excitatory amino-acids, NMDA, AMPA, QUIS and ACPD (e.g. see Fig. 1 and De Curtis et al., 1989). 
Furthermore, it has been demonstrated that the corticofuga1 input to the dLGN (and therefore to the PGN) 
uti1izes an excitatory amino acid as neurotransmitter (Baughman and Gi1bert, 1980; Montero and 
Wentho1d, 1989). Synaptic drive from the dLGN to the cortex a1so uti1izes excitatory amino-acid 
receptors on postsynaptic cells in layer IV of cortex (Hagihara et al., 1988; Fox et al., 1989; Miller et al., 
1989). Clearly, then, the collaterals of these two pathways are likely to use such an excitatory amino-acid 
as neurotransmitter at their synapses on PGN cells, although the postsynaptic receptors involved, at both 
dLGN and PGN leve1s, are stil a matter of debate. Interestingly, work by McConnick and colleagues (Bal 
et al., 1995) has suggested that EPSPs seen in PGN cells during spindle activity are due to activation of 
non-NMDA amino acid receptors (not NMDA receptor activation) arising from activity in the collaterals 
of dLGN relay cells which is, of course, most likely during slow wave sleep and other non-alert states 
when ascending cholinergic activity is diminished. Moreover, based on the prolonged EPSPs recorded in 
guinea pig dLGN relay cells after activation of corticothalamic fibres, it has been suggested that one 
component of the corticofugal input to the dLGN may uti1ize metabotropic excitatory amino acid 
receptors (McConnick and Von Krosigk, 1992). Our data comparing the effects of NOS inhibition on 
responses mediated by NMDA and those mediated by QUIS, which besides its action on ionotropic 
receptors can have agonistic actions on the majority of subtypes of metabotropic receptors (Pin and 
Duvoisin, 1995), and those mediated by the more specific metabotropic agonist ACPD, suggest that NO 
has no action at these sites, even if they are present on PGN cells.  
We have previously hypothesized that the activity of the enzyme NOS, known to be Ca2+ dependent, 
may follow the level of activity in the cholinergic fibres of the parabrachial input, as terminal Ca2+ levels 
fluctuate (Cudeiro et al., 1996), utilizing the increased thalamic pool of arginine known to follow from 
sensory stimulation (Do et al., 1994). With this in mind it is tempting to speculate further that an increase 
in NO levels brought about by increasing parabrachial activity, during arousal or attentive periods, 
enhances the NMDA mediated transmission to the PGN via two different pathways: the activity of the 
relay cell collaterals and input from the visual cortex. Activity in the deep layers of the cortex, from 
which this input to the dLGN/PGN arises, is known to be diminished during sleep and increased during 
arousal (Livingstone and Hubel, 1981). Transition from slow wave sleep to the awake state is known to 
be associated with an increase in neurotransmitter release from many brainstem and hypothalarnic sites, 
including enhanced release of ACh, noradrenaline, 5-hydroxytryptamine (5Ht) and histamine (for a 
review see Steriade and McCarley, 1990; McCormick, 1992). Thus a possible action of the parabrachial 
input would be to enhance cortical input from cells known to have visual receptive fields which are highly 
orientation and direction specific (Grieve and Sillito, 1995) selectively using NMDA receptors, at the 
expense of the relay cell feed-forward inhibition (LGN to PGN to LGN) driven by non-NMDA receptor 
activation, even though relay cell activity can be directly enhanced by both ACh and NO. (The 
importance of the relay cell collateral pathway is likely to be increased during spindle activity, in the 
relative absence of ACh and NO.) It is therefore interesting to note a recent study of the visual properties 
of PGN cells which showed that spontaneous activity was suppressed, while visual responsiveness was 
enhanced, during electrical stimulation of the parabrachium (Murphy et al., 1994). In this scenario, the 
parabrachial production of ACh would globally suppress PGN cell activity by means of muscarinic 
receptors, (perhaps enhancing visual activity with a transient nicotinic activation; see Lee and 
McCormick, 1995), and with release of NO would allow NMDA receptor activation to be enhanced 
relative to non-NMDA. We have illustrated these hypotheses in Figure 7.  
In summary, the simplest explanation of the data we have presented here is to suggest that, as we have 
previously suggested for cells in the dLGN, the actions of NO serve to enhance visual responses of PGN 
cells, in particular those involving the activation of NMDA receptors.  
  
 
 
 
FIG. 7. Diagrammatic representation of the relative weights. of synaptic input to the dLGN/PGN complex in two different 
behavioural states. In A, retinal, parabrachial and cortical influences are minimized (dotted lines), enhancing the activity seen during 
spindles. On the right (B), in an attentive state, there is increased retinal drive, coupled with an increased drive from parabrachial 
cells [utilizing both ACh and NO; ACh produces excitatory effects on dLGN relay cells ( + ) while inhibiting PGN cells (-); 
crucially NO enhances excitatory activity on both sites]. This combination, along with modulatory influences on the cortex which 
directly enhance the visual responsiveness of cells projecting back to the LGN/PGN (see Livingstone and Hubel, 1981), enhances 
corticofugal output and transmission of this influence through the PGN to the dLGN (and of course directly to the dLGN, to both 
relay cells and inhibitory interneurons). Note that, although we allow equal power to the geniculo-cortical and geniculo-PGN paths 
in both states, the form of this activity (spindling in A and visually mediated in B) are markedly different. Clearly in this situation 
the PGN is involved in some visually driven inhibitory mechanism at the level of the LGN during attentive states; the nature of this 
influence is as yet incompletely understood but the relative timing of events may well prove to be of vital importance.  
Acknowledgements  
We are grateful to Dr K. L. Grieve for critical discussion and reading of the manuscript. This research was 
supported by Xunta de Galicia (Ayudas para Infraestructura), DGICYT (PB93-0347) and Vicerrectorado de 
Investigacion (Ayudas para Infraestructura), Universidad de La Coruña, Spain.  
Abbreviations  
ACh acetylcholine  
ACPD ( 1 S.3R)-1-aminocyclopentane-l.3-dicarboxylic acid  
AMPA a-arnino-3-hydroxy-5-5-methyl-4-isoxazole-propionic acid  
APV D-2-arnino-5-phosphonovalerate  
D-Arg D-arginine  
L-Arg L-arginine  
DEA-NO diethylamine-nitric oxide  
dLGN dorsallateral geniculate nucleus  
GABA y-arninobutyric acid  
NADPH nicotinamide adenine dinllcleotide phosphate  
L-NOArg L-NG-nitro-L-arginine  
NOS nitric oxide synthase  
PGN perigeniculate nucleus  
PSTH peristimulus time histograrn  
QUIS quisqualate  
SNAP S-nitroso-N-acetyl penicillamine  
SNP sodium nitroprusside   
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